Damora Therapeutics, Inc. (DMRA) vs Omada Health (OMDA)
A side-by-side comparison of Damora Therapeutics, Inc. and Omada Health across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DMRA
Damora Therapeutics, Inc.
$19.01HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT
OMDA
Omada Health
$20.60HealthcareDelayed quote: Oct 6, 2026, 12:15 PM EDT
Total return — DMRA vs OMDA
growth of $100 · dividends reinvested · last 1yDMRA +518.3% (+518.3%/yr)OMDA -8.9% (-8.9%/yr)DMRA compounded faster over this window
Log scale — wide-divergence pair
DMRA OMDA
DMRA vs OMDA: by the numbers
- •OMDA is the larger company ($1.22B vs $1.17B market cap).
- •OMDA is profitable (1.39% net margin) while DMRA runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | DMRA | OMDA |
|---|---|---|
| P/E ratio | N/A | 327.03 |
| P/S ratio | N/A | 3.95 |
| P/B ratio | 3.03 | 4.85 |
| EV / EBITDA | N/A | 144.56 |
| FCF yield | N/A | 1.64% |
Profitability
| Metric | DMRA | OMDA |
|---|---|---|
| Gross margin | 0.00% | 68.19% |
| Operating margin | 0.00% | -0.15% |
| Net margin | 0.00% | 1.39% |
| ROE | -50.93% | 1.70% |
| ROIC | -52.44% | -0.18% |
Growth (annualized)
| Metric | DMRA | OMDA |
|---|---|---|
| Total return CAGR (5Y) | -25.05% | N/A |
Frequently asked
- Is DMRA or OMDA more profitable?
- OMDA runs the higher net margin — DMRA at 0.00% versus OMDA at 1.39%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.